{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:21:24Z","timestamp":1791487284124,"version":"4.3.4"},"reference-count":39,"publisher":"EDP Sciences","issue":"5","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Des progestatifs, tr\u00e8s utilis\u00e9s en gyn\u00e9cologie, sont d\u00e9sormais clairement associ\u00e9s \u00e0 un risque de m\u00e9ningiome intracr\u00e2nien, surtout en cas d\u2019exposition prolong\u00e9e durant plusieurs ann\u00e9es. Les \u00e9tudes men\u00e9es \u00e0 partir du syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) ont montr\u00e9 une forte relation dose-r\u00e9ponse entre l\u2019utilisation de sept progestatifs (dont ac\u00e9tates de cyprot\u00e9rone, nom\u00e9gestrol, et chlormadinone) et la survenue de m\u00e9ningiomes. Elles ont \u00e9galement confirm\u00e9 une diminution du risque apr\u00e8s l\u2019arr\u00eat du progestatif. Des mesures de restriction des prescriptions, un d\u00e9pistage par imagerie par r\u00e9sonance magn\u00e9tique et l\u2019arr\u00eat des progestatifs \u00e0 risque, en cas de m\u00e9ningiome, ont permis une r\u00e9duction de 90 % des neurochirurgies de m\u00e9ningiomes des femmes sous progestatifs.<\/jats:p>","DOI":"10.1051\/medsci\/2026071","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:54:38Z","timestamp":1780041278000},"page":"486-492","source":"Crossref","is-referenced-by-count":0,"title":["Usage des progestatifs et risque de m\u00e9ningiome intracr\u00e2nien"],"prefix":"10.1051","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-9092","authenticated-orcid":false,"given":"Alain","family":"Weill","sequence":"first","affiliation":[{"name":"Groupement d\u2019int\u00e9r\u00eat scientifique GIS EPI-PHARE, Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9, Caisse nationale de l\u2019assurance maladie","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Oli\u00e9","sequence":"additional","affiliation":[{"name":"Groupement d\u2019int\u00e9r\u00eat scientifique GIS EPI-PHARE, Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9, Caisse nationale de l\u2019assurance maladie","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[{"name":"Groupement d\u2019int\u00e9r\u00eat scientifique GIS EPI-PHARE, Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9, Caisse nationale de l\u2019assurance maladie","place":["France"]},{"name":"Universit\u00e9 Versailles St-Quentin-en-Yvelines","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Froelich","sequence":"additional","affiliation":[{"name":"D\u00e9partement de neurochirurgie, H\u00f4pital Lariboisi\u00e8re, Paris-Cit\u00e9 universit\u00e9, APHP","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1051\/medsci\/2022151","volume":"38","author":"Johnson","year":"2022","journal-title":"Med Sci (Paris)"},{"key":"R2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","volume":"27","author":"Price","year":"2025","journal-title":"Neuro Oncol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neuro-Oncol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0090-3019(86)90255-7","volume":"26","author":"Maiuri","year":"1986","journal-title":"Surg Neurol"},{"key":"R6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMc071938","volume":"357","author":"Gazzeri","year":"2007","journal-title":"N Engl J Med"},{"key":"R7","first-page":"S317","volume":"28S","author":"Froelich","year":"2007","journal-title":"Rev Med Int"},{"key":"R8","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","volume":"157","author":"Bernat","year":"2015","journal-title":"Acta Neurochir"},{"key":"R9","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3174\/ajnr.A1978","volume":"31","author":"Gon\u00e7alves","year":"2010","journal-title":"Amn J Neuroradiol"},{"key":"R10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.23736\/S0390-5616.16.03417-2","volume":"61","author":"Zairi","year":"2017","journal-title":"J Neurosurg Sci"},{"key":"R11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/neuros\/nyab175","volume":"89","author":"Voormolen","year":"2021","journal-title":"Neurosurgery"},{"key":"R12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00701-019-03848-x","volume":"161","author":"Passeri","year":"2019","journal-title":"Acta Neurochir (Wien)"},{"key":"R13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-021-03696-9","volume":"152","author":"Malaize","year":"2021","journal-title":"J Neurooncol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"e70078","DOI":"10.1002\/pds.70078","volume":"34","author":"Roland","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/annonc\/mdx763","volume":"29","author":"Peyre","year":"2018","journal-title":"Ann Oncol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00701-021-05005-9","volume":"164","author":"Passeri","year":"2022","journal-title":"Acta Neurochir (Wien)"},{"key":"R17","doi-asserted-by":"crossref","first-page":"n37","DOI":"10.1136\/bmj.n37","volume":"372","author":"Weill","year":"2021","journal-title":"BMJ"},{"key":"R18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/jnnp-2021-326138","volume":"93","author":"Mikkelsen","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/ene.15423","volume":"29","author":"Hoisnard","year":"2022","journal-title":"Eur J Neurol"},{"key":"R20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awy108","volume":"141","author":"Nota","year":"2018","journal-title":"Brain"},{"key":"R21","doi-asserted-by":"crossref","first-page":"100928","DOI":"10.1016\/j.lanepe.2024.100928","volume":"42","author":"Nguyen","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"R22","doi-asserted-by":"crossref","first-page":"e16505","DOI":"10.1111\/ene.16505","volume":"32","author":"Roland","year":"2025","journal-title":"Eur J Neurol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"e078078","DOI":"10.1136\/bmj-2023-078078","volume":"384","author":"Roland","year":"2024","journal-title":"BMJ"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Roland N, Jourdain H, Kolla E, et al. Use of the injectable contraceptive medroxyprogesterone acetate in France in 2010-2023: a national descriptive study. Therapie 2026 ; S0040-5957(26)00035-1.","DOI":"10.1016\/j.therap.2025.11.013"},{"key":"R25","doi-asserted-by":"crossref","first-page":"1470539","DOI":"10.3389\/fgwh.2025.1470539","volume":"6","author":"Roland","year":"2025","journal-title":"Front Glob Womens Health"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Frey C, Sodhi M, Fatehi M, et al. Use of medroxyprogesterone acetate and risk of meningiomas: a comparative safety study. Expert Opin Drug Saf 2025 ; 1\u20134.","DOI":"10.1080\/14740338.2025.2526787"},{"key":"R27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/curroncol32070401","volume":"32","author":"Griffin","year":"2025","journal-title":"Curr Oncol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaneurol.2025.3011","volume":"82","author":"Xiao","year":"2025","journal-title":"JAMA Neurol"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Tettamanti G, Shu X, Mogensen H, et al. Hormonal contraceptives and the risk of meningioma: a Swedish register-based case-control study. Neuro Oncol 2025 ; noaf228.","DOI":"10.1093\/neuonc\/noaf228"},{"key":"R30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/epidemiologia6040058","volume":"6","author":"Reynolds","year":"2025","journal-title":"Epidemiologia (Basel)"},{"key":"R31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11060-025-05402-5","volume":"176","author":"Chen","year":"2026","journal-title":"J Neurooncol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"e083981","DOI":"10.1136\/bmj-2024-083981","volume":"389","author":"Roland","year":"2025","journal-title":"BMJ"},{"key":"R33","first-page":"202806","volume":"73","author":"Roland","year":"2025","journal-title":"J Epidemiol Community Health"},{"key":"R34","unstructured":"Haute autorit\u00e9 de Sant\u00e9. Sp\u00e9cialit\u00e9s indiqu\u00e9es dans le traitement hormonal de la m\u00e9nopause - R\u00e9\u00e9valuation sur saisine minist\u00e9rielle. 2025. https:\/\/www.has-sante.fr\/jcms\/p_3689712\/en\/reevaluation-des-specialites-indiquees-dans-le-traitement-hormonal-de-la-menopause-estradiol-estriol-tibolone-acetate-de-cyproterone-dydrogesterone-levonorgestrel-medrogestone-medroxyprogesterone-acetate-de-norethisterone-progesterone"},{"key":"R35","unstructured":"https:\/\/www.epi-phare.fr\/rapports-detudes-et-publications\/impact-mesures-nomegestrol-chlormadinone-meningiomes\/"},{"key":"R36","unstructured":"https:\/\/www.ema.europa.eu\/en\/news\/restrictions-use-cyproterone-due-meningioma-risk-0"},{"key":"R37","unstructured":"https:\/\/www.ema.europa.eu\/fr\/documents\/referral\/new-measures-minimise-risk-meningioma-medicines-containing-nomegestrol-or-chlormadinone_fr.pdf"},{"key":"R38","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/dhpc\/medroxyprogesterone-acetate"},{"key":"R39","doi-asserted-by":"crossref","first-page":"r1095","DOI":"10.1136\/bmj.r1095","volume":"389","author":"Reuter","year":"2025","journal-title":"BMJ"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2026071\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2026071\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:48:24Z","timestamp":1791485304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2026071"}},"subtitle":["Nouvelles donn\u00e9es et enjeux cliniques"],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"journal-issue":{"issue":"5"},"alternative-id":["medsci20260026"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2026071","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}